clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02122718 |
P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
P17 | country | United Kingdom | Q145 |
P582 | end time | 2018-09-01 | |
P1050 | medical condition | stroke | Q12202 |
ischemia | Q188151 | ||
cerebral infarction | Q1209150 | ||
P2899 | minimum age | 50 | |
P1132 | number of participants | 464 | |
P6153 | research site | University of Nottingham | Q472316 |
Leeds Teaching Hospitals NHS Trust | Q6516115 | ||
NHS Grampian | Q6954137 | ||
NHS Tayside | Q6954176 | ||
The Royal London Hospital | Q7374421 | ||
P1813 | short name | XILO-FIST | |
P580 | start time | 2014-05-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack |
Search more.